Compare MANU & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MANU | ICUI |
|---|---|---|
| Founded | 1878 | 1984 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.0B |
| IPO Year | 2012 | 1995 |
| Metric | MANU | ICUI |
|---|---|---|
| Price | $19.97 | $122.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $169.00 |
| AVG Volume (30 Days) | ★ 256.0K | 234.6K |
| Earning Date | 06-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.62 |
| EPS | N/A | ★ 1.20 |
| Revenue | N/A | ★ $2,231,262,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.31 | $4.46 |
| P/E Ratio | ★ N/A | $102.56 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.22 | $107.02 |
| 52 Week High | $20.12 | $160.29 |
| Indicator | MANU | ICUI |
|---|---|---|
| Relative Strength Index (RSI) | 65.05 | 48.61 |
| Support Level | $15.09 | $121.52 |
| Resistance Level | N/A | $125.00 |
| Average True Range (ATR) | 0.70 | 4.65 |
| MACD | 0.11 | 0.47 |
| Stochastic Oscillator | 95.16 | 44.14 |
Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extends to many countries, supporting a diversified revenue model based on brand engagement and football-related content.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.